Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma

Background and Aim. The epithelial cell adhesion molecule (EpCAM) has been proposed as a marker for cancer stem cells in human hepatocellular carcinoma (HCC) as well as in the development of novel target therapies. This study aimed to investigate the immunohistochemical expression of EpCAM and alpha...

Full description

Saved in:
Bibliographic Details
Main Authors: Leonardo do Prado Lima, Carla Jorge Machado, João Bernardo Sancio Rocha Rodrigues, Leonardo de Souza Vasconcellos, Eduardo Paulino Junior, Paula Vieira Teixeira Vidigal, Vivian Resende
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2018/5970852
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564225048838144
author Leonardo do Prado Lima
Carla Jorge Machado
João Bernardo Sancio Rocha Rodrigues
Leonardo de Souza Vasconcellos
Eduardo Paulino Junior
Paula Vieira Teixeira Vidigal
Vivian Resende
author_facet Leonardo do Prado Lima
Carla Jorge Machado
João Bernardo Sancio Rocha Rodrigues
Leonardo de Souza Vasconcellos
Eduardo Paulino Junior
Paula Vieira Teixeira Vidigal
Vivian Resende
author_sort Leonardo do Prado Lima
collection DOAJ
description Background and Aim. The epithelial cell adhesion molecule (EpCAM) has been proposed as a marker for cancer stem cells in human hepatocellular carcinoma (HCC) as well as in the development of novel target therapies. This study aimed to investigate the immunohistochemical expression of EpCAM and alpha-fetoprotein (AFP) in HCC patients and their association with clinicopathological characteristics. Methods. This study included Child-Pugh A HCC patients undergoing curative surgical resection. Results. A significant difference was observed in the ratio between the different phenotypes (p = 0.002), identifying 12 (29.3%) EPCAM positive tumors and 29 (70.7%) negative tumors. EpCAM+ expression was associated with AFP + (OR = 12.5, 95% CI, 1.9-84.1, p<0.001). In univariate analysis, a significant association was observed between AFP+ and EPCAM+ and the serum AFP level. A diameter of ≤ 5 cm was associated with EPCAM+, while angiolymphatic invasion was associated with APF+. In a multivariate analysis, only tumors of ≤ 5 cm were significantly associated with EpCAM+ (OR = 8.7; 95%CI, 1.27-100.0; p = 0.022). The overall survival rate was 74.9%, 69.4%, 69.4%, and 53.5% at 12, 24, 36, and 48 months, respectively. Conclusion. A considerable number of patients with EpCAM+ HCC would benefit from a specific target therapy.
format Article
id doaj-art-d450d2e70b0940549b113fbc9770f7ee
institution Kabale University
issn 2291-2789
2291-2797
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-d450d2e70b0940549b113fbc9770f7ee2025-02-03T01:11:33ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27892291-27972018-01-01201810.1155/2018/59708525970852Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular CarcinomaLeonardo do Prado Lima0Carla Jorge Machado1João Bernardo Sancio Rocha Rodrigues2Leonardo de Souza Vasconcellos3Eduardo Paulino Junior4Paula Vieira Teixeira Vidigal5Vivian Resende6Departamento de Cirurgia, Hospital das Clínicas da Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilDepartamento de Medicina Social e Preventiva da Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilDepartamento de Cirurgia, Hospital das Clínicas da Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilDepartamento de Patologia Clínica, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilDepartamento de Histopatologia da Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilDepartamento de Histopatologia da Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilDepartamento de Cirurgia, Hospital das Clínicas da Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, BrazilBackground and Aim. The epithelial cell adhesion molecule (EpCAM) has been proposed as a marker for cancer stem cells in human hepatocellular carcinoma (HCC) as well as in the development of novel target therapies. This study aimed to investigate the immunohistochemical expression of EpCAM and alpha-fetoprotein (AFP) in HCC patients and their association with clinicopathological characteristics. Methods. This study included Child-Pugh A HCC patients undergoing curative surgical resection. Results. A significant difference was observed in the ratio between the different phenotypes (p = 0.002), identifying 12 (29.3%) EPCAM positive tumors and 29 (70.7%) negative tumors. EpCAM+ expression was associated with AFP + (OR = 12.5, 95% CI, 1.9-84.1, p<0.001). In univariate analysis, a significant association was observed between AFP+ and EPCAM+ and the serum AFP level. A diameter of ≤ 5 cm was associated with EPCAM+, while angiolymphatic invasion was associated with APF+. In a multivariate analysis, only tumors of ≤ 5 cm were significantly associated with EpCAM+ (OR = 8.7; 95%CI, 1.27-100.0; p = 0.022). The overall survival rate was 74.9%, 69.4%, 69.4%, and 53.5% at 12, 24, 36, and 48 months, respectively. Conclusion. A considerable number of patients with EpCAM+ HCC would benefit from a specific target therapy.http://dx.doi.org/10.1155/2018/5970852
spellingShingle Leonardo do Prado Lima
Carla Jorge Machado
João Bernardo Sancio Rocha Rodrigues
Leonardo de Souza Vasconcellos
Eduardo Paulino Junior
Paula Vieira Teixeira Vidigal
Vivian Resende
Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma
Canadian Journal of Gastroenterology and Hepatology
title Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma
title_full Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma
title_fullStr Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma
title_full_unstemmed Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma
title_short Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma
title_sort immunohistochemical coexpression of epithelial cell adhesion molecule and alpha fetoprotein in hepatocellular carcinoma
url http://dx.doi.org/10.1155/2018/5970852
work_keys_str_mv AT leonardodopradolima immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma
AT carlajorgemachado immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma
AT joaobernardosanciorocharodrigues immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma
AT leonardodesouzavasconcellos immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma
AT eduardopaulinojunior immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma
AT paulavieirateixeiravidigal immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma
AT vivianresende immunohistochemicalcoexpressionofepithelialcelladhesionmoleculeandalphafetoproteininhepatocellularcarcinoma